#TMP-301
LightNews LightNews
new3rd.bsky.social
ネクセラファーマの提携先Tempero Bio社がアルコール依存症治療に向けた試験をスタート#ネクセラファーマ#Tempero_Bio#TMP-301

ネクセラファーマの提携先Tempero Bio社が、アルコール依存症を対象としたTMP-301のフェーズ2試験を開始しました。治療の視界を広げる新たな一歩です。
ネクセラファーマの提携先Tempero Bio社がアルコール依存症治療に向けた試験をスタート
ネクセラファーマの提携先Tempero Bio社が、アルコール依存症を対象としたTMP-301のフェーズ2試験を開始しました。治療の視界を広げる新たな一歩です。
news.3rd-in.co.jp
March 24, 2025 at 11:49 PM
endpts.com
Tempero Bio raises $70M for TMP-301, a daily pill in development for alcohol and cocaine use disorders. Phase 2 data expected in 2026.
endpts.com/tempero-bio-...
Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders
A small Oakland, CA-based biotech hoping to take on the sprawling landscape of substance use disorders and addiction has reeled in $70 million. The drug development startup, named Tempero Bio ...
endpts.com
March 24, 2025 at 7:38 PM
kstheresatrapp.bsky.social
hayspost.com/posts/cfa26a...
Hays, KS area cancellations and delays.
Please email hayspost@eaglemedia.com to add your cancellation (preferred and quickest method). You can also call 785-301-2211 to add your cancellation. Leave a voicemail if no one answers.
Latest cancellations and delays
---------------------------------------------------------Friday, January 23, 2026High school sportsThe TMP-Marian boys and girls games on
hayspost.com
January 23, 2026 at 12:20 PM
azgeoff.bsky.social
www.prnewswire.com/news-release...
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
/PRNewswire/ -- Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced...
www.prnewswire.com
March 25, 2025 at 7:52 PM
longtail-news.bsky.social
Feed: "Endpoints News"
By: Kyle LaHucik on Monday, November 3, 2025
Tempero halts substance use disorder drug, is 'assessing strategic alternatives'
Tempero Bio halts Phase 2 trial of TMP-301 for alcohol use disorder and seeks strategic alternatives, per Nxera Pharma update.
endpoints.news
November 4, 2025 at 4:35 AM
newsen.bsky.social
Tempero Bio Raises $70 Million to Propel TMP-301 into Phase 2 Trials for Substance Use Disorders#United_States#Oakland#Substance_Use#Tempero_Bio#TMP-301
Tempero Bio Raises $70 Million to Propel TMP-301 into Phase 2 Trials for Substance Use Disorders
Tempero Bio has successfully secured $70 million in Series B financing to progress TMP-301 toward Phase 2 clinical trials for substance use disorders, addressing a critical public health issue.
third-news.com
March 24, 2025 at 11:04 AM
l2plabs.bsky.social
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
Funding will support two Phase 2 clinical trials in alcohol and cocaine use disorders Company has initiated Phase 2 study in alcohol use disorder and plans to initiate cocaine studies over the next year John Wagner M.D., Ph.D. to join as Chief Medical Officer OAKLAND, Calif., March 24,...
dlvr.it
March 24, 2025 at 11:11 AM